$GWPH GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) has a PDUFA action date, with the FDA due to announce its verdict on the company's sNDA for Epidiolex for the treatment of seizures associated with tuberous sclerosis complex. (Friday)
  • 2
2 Likes